SeS2 inhibited the growth of and induced apoptosis in HCC cells by inhibiting the expression of PLAGL2, thereby suppressing downstream C‐MET/STAT3, AKT/mTOR, and MAPK signaling. The gene discussed is AKT1; the disease is hepatocellular carcinoma.